Atara Bio reiterated at Buy by Canaccord on expected Ebvallo manufacture
Canaccord Genuity adjusted its price target on Atara Biotherapeutics (NASDAQ:ATRA) shares, reducing it to $17 from the previous $21, while maintaining a Buy rating.
Blazers Predicted to Land $75M Star For Anfernee Simons
Jan 11, 2025; Portland, Oregon, USA; Portland Trail Blazers guard Anfernee Simons (1) grabs a rebound during the second half against Miami Heat guard Jaime Jaquez Jr. (11) at Moda Center. Mandatory ...
Richmond2d
FDA bans red dye No. 3 from foods
U.S. regulators on Wednesday banned the dye called Red 3 from the nation's food supply, nearly 35 years after it was barred ...
Aralon picks up industrial building in SF’s Showplace Square for $12M
Developer picks up 72K sf building for $160 psf after Swift Real Estate failed to pay loan tied to 101 Utah Street.
Hosted on MSN8d
The Final Falafel? Missoula's Acropolis Gyros up for sale
When it comes to purchasing a used car, German engineering often tops the list for those who want luxury and performance, but ...
Forbes25d
Samsung Galaxy S24 Ultra Price Cut Heavily In Sudden Flash Sale
However, Best Buy has just suddenly launched a Doorbuster sale which takes $350 off the price of the S24 Ultra with 256GB storage, taking the total down to $949.99. This price is for the Titanium ...